MCID and 2mg/kg x 2 dosage is now critical to ensuring both primary end points are met with a clear margin.
Should be interesting month or 2 ahead with potential trifecta of news.
The share price is unlikely to gravitate around PARO exercise if positive outcomes from agencies IMO.
- Forums
- ASX - By Stock
- The (Painful) Competition
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.38%
!
43.0¢

MCID and 2mg/kg x 2 dosage is now critical to ensuring both...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
43.0¢ |
Change
0.010(2.38%) |
Mkt cap ! $170.8M |
Open | High | Low | Value | Volume |
42.5¢ | 43.5¢ | 42.0¢ | $142.7K | 336.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 75182 | 42.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.0¢ | 63388 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 75450 | 0.425 |
2 | 3522 | 0.420 |
4 | 26685 | 0.415 |
3 | 34146 | 0.410 |
3 | 22849 | 0.405 |
Price($) | Vol. | No. |
---|---|---|
0.430 | 63392 | 5 |
0.435 | 5237 | 2 |
0.440 | 46545 | 3 |
0.445 | 41733 | 6 |
0.450 | 154384 | 6 |
Last trade - 13.40pm 15/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online